首页>
外国专利>
5,10 DIOXIDES OF PYRIMIDO(4,5-B)QUINOXALINE AND THEIR SALTS,THEIR PRODUCTION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
5,10 DIOXIDES OF PYRIMIDO(4,5-B)QUINOXALINE AND THEIR SALTS,THEIR PRODUCTION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
展开▼
机译:5,10嘧啶酮(4,5-B)喹诺沙星及其盐,其生产和组成的药理成分
展开▼
页面导航
摘要
著录项
相似文献
摘要
1365442 Pyrimido[4,5b]quinoxalines BAYER AG 5 May 1972 [7 May 1971] 21036/72 Heading C2C Novel compounds of Formula I wherein RSP1/SP and RSP2/SP are alkyl, alkoxyalkyl or with the N atom form a 5, 6 or 7 membered heterocyclic ring which may contain oxygen as a ring atom are prepared by base cyclization of a compound of Formula V Intermediates of Formula V above are prepared by reaction of a compound of Formula II with phosgene or an alkyl chloroformate. Pharmaceutical compositions in conventional forms for oral, rectal, parenteral or topical administration and having anti-bacterial activity and growth promoting activity comprise an above novel compound in admixture with carriers and/or diluents or fodder other than a solvent of molecular weight less than 200 or a surface active ingredient. Methods of use of the above compounds and compositions as antibacterial agents and growth promoters is also claimed.
展开▼
机译:1365442嘧啶[4,5b]喹喔啉BAYER AG 1972年5月5日[1971年5月7日]标题C2C其中R 1 SP>和R 2 SP>的式I新型化合物,烷氧基烷基或与N原子形成可含有氧作为环原子的5元,6元或7元杂环是通过式V化合物的碱环化制备的。式V的中间体是通过式V化合物的反应制备的。 II用光气或氯甲酸烷基酯。用于口服,直肠,肠胃外或局部给药并具有抗菌活性和促进生长活性的常规形式的药物组合物包含上述新型化合物,与分子量小于200或小于200的溶剂以外的载体和/或稀释剂或饲料混合表面活性成分。还要求保护上述化合物和组合物作为抗菌剂和生长促进剂的方法。
展开▼